In hepatoma cells, primary glioma and esophageal squamous cell carcinoma cells DISC analysis revealed that bortezomib enhanced the recruitment of TRAIL-receptors, FADD and caspase-8 upon rhTRAIL stimulation [35, 37, 38]. The gene discussed is FADD; the disease is hepatocellular carcinoma.